Educated at the University of California-Davis School of Medicine, Dr. ZoAnn Dreyer is Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine and Medical Director of the Long-Term Survivor Program at Texas Children’s Cancer Center. The Program evaluates over 1,000 childhood cancer survivors every one to two years for delayed effects of their prior cancer therapy. Survivors are patients who are more than five years from their diagnosis and off therapy at least two years. There is no upper age limit for survivors followed in the Program. Dr. Dreyer’s additional clinical research interests include acute lymphoid leukemia in infants younger than one year old. She was the principal investigator for an innovative, nationwide treatment protocol for these infants that have resulted in dramatically improved survival rates. She is currently principal investigator of a new pilot study using intensified asparaginase in patients with high risk ALL. She is also an active member of the Leukemia/Lymphoma and Hematology teams at the Cancer Center. Dr. Dreyer is very involved in outreach and public affairs and is frequently featured in medical news stories involving Baylor College of Medicine and Texas Children’s Hospital.